IRON BINDING CAPACITY TOTAL ABNORMAL

This adverse event was reported 23 times

These drugs are most commonly taken by patients reporting IRON BINDING CAPACITY TOTAL ABNORMAL:

# Drug Count
0 ERYTHROPOIETIN 3
1 ADALIMUMAB 2
2 AMLODIPINE 2
3 ASPIRIN 2
4 ASPIRIN 325 MG 2
5 ASPIRIN 81 MG 2
6 EPOETIN ALFA 2
7 FUROSEMIDE 2
8 GLIPIZIDE 2
9 OMEPRAZOLE 2
See all common drugs associated with IRON BINDING CAPACITY TOTAL ABNORMAL

IRON BINDING CAPACITY TOTAL ABNORMAL is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 FERRIC CITRATE 1 0.0005
1 SODIUM ZIRCONIUM CYCLOSILICATE 1 0.0002
2 EPOETIN ALFA 2 0.0002
3 ETODOLAC 1 0.0002
4 ACLIDINIUM BROMIDE 1 0.0002
5 ERYTHROPOIETIN 3 0.0001
6 DASPONE 1 0.0001
7 DAPSONE GEL, 5% 1 0.0001
8 CLOBETASOL PROPIONATE OINTMENT USP, 0.05% 1 0.0001
9 CLOBETASOL PROPIONATE 1 0.0001
See all drugs enriched for association with IRON BINDING CAPACITY TOTAL ABNORMAL

IRON BINDING CAPACITY TOTAL ABNORMAL is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Sulfone [EPC] 1 0.0001
1 GLP-2 Analog [EPC] 1 0.0001
2 CD52-directed Cytolytic Antibody [EPC] 1 0.0001
3 Iron Chelator [EPC] 1 0.0000
4 Central alpha-2 Adrenergic Agonist [EPC] 1 0.0000
5 Erythropoiesis-stimulating Agent [EPC] 1 0.0000
6 Complement Inhibitor [EPC] 1 0.0000
7 Sulfonylurea [EPC] 2 0.0000
8 Potassium Channel Blocker [EPC] 1 0.0000
9 Cardiac Glycoside [EPC] 1 0.0000
See all drug classes enriched for association with IRON BINDING CAPACITY TOTAL ABNORMAL